AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2015

Jun 12, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2015-06-10

Reporting Person: Higgons John Duncan (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-10	Common stock	M	10000	$0.3025	Acquired	108835	Direct
2015-06-11	Common stock	M	10000	$0.3025	Acquired	118835	Direct
2015-06-12	Common stock	M	10000	$0.3025	Acquired	128835	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-10	Stock option (right to buy)	$0.3025	M	10000	Disposed	2019-08-12	Common stock (10000)	Direct
2015-06-11	Stock option (right to buy)	$0.3025	M	10000	Disposed	2019-08-12	Common stock (10000)	Direct
2015-06-12	Stock option (right to buy)	$0.3025	M	10000	Disposed	2019-08-12	Common stock (10000)	Direct

Footnotes

F1: This option was granted on August 13, 2009. The shares underlying this option vest as to 25% of the shares on May 18, 2010, with the remaining 75% vesting in 36 equal monthly installments thereafter.